MktsMarkets

Kiniksa Pharmaceuticals International, plc
NASDAQ: KNSAKey statistics
KNSA News
Stories mentioning KNSA from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 214,266 | 202,127 | 180,855 | 156,797 | 137,785 | 122,536 | 112,214 | 108,631 |
| Cost of Goods Sold | 20,796 | 20,945 | 20,257 | 18,603 | 17,868 | 17,896 | 20,109 | 12,322 |
| Gross Profit | 193,470 | 181,182 | 160,598 | 138,194 | 119,917 | 104,640 | 92,105 | 96,309 |
| Operating Expenses | ||||||||
| Research & Development | 27,475 | 34,609 | 24,166 | 18,753 | 19,325 | 35,215 | 26,057 | 24,017 |
| Sales General & Admin | 61,151 | 56,775 | 49,104 | 46,863 | 43,530 | 40,535 | 46,399 | 42,395 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 29,267 | 19,768 | 24,021 | 20,160 | 13,272 | (19,299) | (9,658) | (117.00) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | 32,681 | 23,269 | 27,157 | 22,877 | 15,565 | (16,979) | (7,201) | 2,304 |
| Tax Provision | 10,089 | 9,070 | 8,722 | 5,045 | 7,026 | (8,091) | 5,492 | 6,212 |
| Net Income (Loss) | 22,592 | 14,199 | 18,435 | 17,832 | 8,539 | (8,888) | (12,693) | (3,908) |
| Earnings Per Share (Basic) | 0.30 | 0.19 | 0.25 | 0.24 | 0.12 | (0.12) | (0.18) | (0.06) |
| Earnings Per Share (Diluted) | 0.27 | 0.18 | 0.23 | 0.23 | 0.11 | (0.12) | (0.18) | (0.06) |
| Weighted Average Shares Outstanding (Basic) | 76,517 | 74,201 | 74,715 | 73,439 | 72,647 | 71,424 | 71,727 | 71,005 |
| Weighted Average Shares Outstanding (Diluted) | 82,410 | 78,979 | 80,035 | 77,942 | 76,146 | 71,424 | 71,727 | 71,005 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About KNSA
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA) is a stock listed on the Nasdaq Stock Market under the ticker symbol KNSA. It last traded at $88.34 (Nov 5, 2026, 4:00 PM ET), down 8.1% on the day. That gives Kiniksa Pharmaceuticals International a market capitalisation of $7.1B and a price-to-earnings ratio of 88.1.
Over the past 52 weeks KNSA has traded between $37.02 and $98.48.
Revenue for the quarter ended Mar 31, 2026 was $214.3M; net income $22.6M. Revenue was up 55.5% from $137.8M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $214.3M | $22.6M | 10.5% |
| Dec 31, 2025 | $202.1M | $14.2M | 7.0% |
| Sep 30, 2025 | $180.9M | $18.4M | 10.2% |
| Jun 30, 2025 | $156.8M | $17.8M | 11.4% |
From Kiniksa Pharmaceuticals International’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…